May Tech Global Investments, LLC Acelrx Pharmaceuticals Inc Transaction History

May Tech Global Investments, LLC

  • $755 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
BUY
$1.03 - $1.7 $52,787 - $87,125
51,250 New
51,250 $71,000

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track May Tech Global Investments, LLC Portfolio

Follow May Tech Global Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of May Tech Global Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on May Tech Global Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email